Guerbet
Offers medical imaging solutions, from contrast agents to AI, for healthcare professionals.
GBT | PA
Overview
Corporate Details
- ISIN(s):
- FR0000032526 (+3 more)
- LEI:
- 969500WV1U1WQ059L135
- Country:
- France
- Address:
- 15 RUE DES VANESSES, 93420 VILLEPINTE
- Website:
- https://www.guerbet.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Guerbet is a global leader in medical imaging, specializing in diagnostic and interventional imaging solutions for healthcare professionals. Since its establishment in 1926, the company has developed and commercialized a comprehensive portfolio that includes contrast agents, medical devices, delivery systems, and digital and AI-powered solutions. Guerbet's products are utilized to improve the diagnosis and treatment of major disease areas such as cancer, as well as cardiovascular, inflammatory, and neurodegenerative diseases. The company focuses on providing innovative and safe solutions to enhance patient care and support radiology professionals worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-02 17:45 |
Business and Financial Review
GUERBET : Ajustement des objectifs financiers 2025.
|
French | 157.0 KB | ||
| 2025-12-02 17:45 |
Earnings Release
GUERBET : Adjustment of 2025 financial targets.
|
English | 150.5 KB | ||
| 2025-11-24 17:44 |
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
|
French | 153.1 KB | ||
| 2025-11-19 13:47 |
Report Publication Announcement
GUERBET : Calendrier financier de l’exercice 2026
|
French | 198.7 KB | ||
| 2025-11-19 13:47 |
Report Publication Announcement
GUERBET : Financial agenda for 2026
|
English | 172.2 KB | ||
| 2025-10-23 17:45 |
Earnings Release
Guerbet : Chiffre d’affaires au 30 septembre 2025. Retour de la croissance au 3…
|
French | 294.9 KB | ||
| 2025-10-23 17:45 |
Earnings Release
Guerbet : Revenue at September 30, 2025. Return to growth in Q3 2025. Confirmat…
|
English | 305.6 KB | ||
| 2025-10-14 17:30 |
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
|
French | 158.6 KB | ||
| 2025-09-24 17:45 |
Earnings Release
Guerbet : H1 2025 results : H1 revenue: €387.8 million, down 5.4% at CER and on…
|
English | 524.6 KB | ||
| 2025-09-24 17:45 |
Earnings Release
Guerbet : Résultats semestriels 2025 : Chiffre d’affaires du 1er semestre : 387…
|
French | 496.3 KB | ||
| 2025-09-22 17:45 |
Board/Management Information
Guerbet : Evolution de la Direction Générale
|
French | 134.4 KB | ||
| 2025-09-22 17:45 |
Board/Management Information
Guerbet : Change in General Management
|
English | 113.8 KB | ||
| 2025-09-18 17:45 |
Declaration of Voting Results & Voting Rights Announcements
GUERBET : Nombre d'actions et de droits de vote composant le capital de la soci…
|
French | 159.1 KB | ||
| 2025-09-15 17:50 |
Earnings Release
Guerbet : Ajustement des objectifs financiers annuels 2025
|
French | 209.3 KB | ||
| 2025-09-15 17:50 |
Earnings Release
Guerbet : Adjustment of 2025 full-year financial targets
|
English | 186.1 KB |
Automate Your Workflow. Get a real-time feed of all Guerbet filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Guerbet
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Guerbet via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-19 | N/A | Other | Buy | 142 | 4,989.31 EUR |
| 2024-08-15 | N/A | Other | Buy | 195 | 6,678.75 EUR |
| 2024-08-12 | N/A | Other | Buy | 1,000 | 34,350.00 EUR |
| 2024-04-18 | N/A | Other | Sell | 550 | 17,699.00 EUR |
| 2023-11-30 | N/A | Other | Sell | 700 | 12,684.00 EUR |
| 2023-11-03 | N/A | Other | Buy | 1 | 17.92 EUR |
| 2023-10-30 | N/A | Other | Buy | 1,000 | 17,000.00 EUR |
| 2023-10-25 | N/A | Other | Buy | 1,000 | 16,800.00 EUR |
| 2023-10-24 | N/A | Other | Buy | 1,000 | 16,460.90 EUR |
| 2023-05-04 | N/A | Other | Buy | 300 | 4,938.00 EUR |
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}